CISD2 and fatty liver disease: Altogether, our mouse studies show that CISD2 plays a pivotal role in protecting the liver from WD-induced NASH, and that CISD2 is a promising molecular target for the development of therapeutic agents for the treatment of WD-induced fatty liver diseases [37,55].